Led Telum Therapeutics' €18 million Series A financing round to advance treatments for hospital-acquired infections.
Telum Therapeutics is a biotechnology company specializing in drug discovery, leveraging synthetic biology and AI-driven machine learning to develop next-generation antimicrobial solutions
Telum Therapeutics is a biotechnology company specializing in drug discovery, leveraging synthetic biology and AI-driven machine learning to develop next-generation antimicrobial solutions. The company focuses on engineered phage lytic proteins to combat multidrug-resistant infections.